At Nortem BioGroup, we value transparency and trust in our relationship with investors. In this Communication section, you will find relevant and up-to-date information on our company’s performance, important events, financial announcements and other significant news. We are committed to keeping you informed about our progress, strategies and results, providing easy and direct access to all the data you need to make informed investment decisions.
Members are convened at 9.00 am. on 08 July 2024 at the registered office of the company to the extraordinary shareholders' meeting for the approval, if necessary, of the amendment of the Articles of Association to enable the issuance of non-voting shares.
The Board of Directors is convened at 8.00 a.m. on 08 July 2024 at the registered office of the company for the dismissal of the current secretary non-director and for the revocation of the current powers granted to the dismissed secretary. And for the appointment of the secretary of the board, and of the managing director.
The shareholders of Nortem Chem S.A. are hereby summoned to the ordinary meeting to be held on 28 June 2024, with the sole agenda of approving the accounts for 2023.
The directors are called to meet on 31 March to formulate the annual accounts for 2024.